| The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. | |
| | |
MedLine Citation:
|
PMID: 21392619 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The Occluded Artery Trial (OAT) showed no difference in outcomes between percutaneous coronary intervention (PCI) versus optimal medical therapy (MED) in patients with persistent total occlusion of the infarct-related artery 3 to 28 days post-myocardial infarction. Whether PCI may benefit a subset of patients with preservation of infarct zone (IZ) viability is unknown. METHODS AND RESULTS: The OAT nuclear ancillary study hypothesized that (1) IZ viability influences left ventricular (LV) remodeling and that (2) PCI as compared with MED attenuates adverse remodeling in post-myocardial infarction patients with preserved viability. Enrolled were 124 OAT patients who underwent resting nitroglycerin-enhanced technetium-99m sestamibi single-photon emission computed tomography (SPECT) before OAT randomization, with repeat imaging at 1 year. All images were quantitatively analyzed for infarct size, IZ viability, LV volumes, and function in a core laboratory. At baseline, mean infarct size was 26% ± 18 of the LV, mean IZ viability was 43% ± 8 of peak uptake, and most patients (70%) had at least moderately retained IZ viability. There were no significant differences in 1-year end-diastolic or end-systolic volume change between those with severely reduced versus moderately retained IZ viability, or when compared by treatment assignment PCI versus MED. In multivariable models, increasing baseline viability independently predicted improvement in ejection fraction (P = .005). There was no interaction between IZ viability and treatment assignment for any measure of LV remodeling. CONCLUSIONS: In the contemporary era of MED, PCI of the infarct-related artery compared with MED alone does not impact LV remodeling irrespective of IZ viability. |
| | |
Authors:
|
James E Udelson; Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; Jose Antonio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman |
Related Documents
:
|
16920359 - Raised troponin t in inclusion body myositis is common and serum levels are persistent ... 20464269 - [evaluation of longitudinal systolic function in heart failure with normal ejection fra... 21167349 - Obesity paradox and risk of sudden death in heart failure results from the muerte subit... 21292649 - A case of difficult temporary pacing. 14736289 - Biochemical markers of myocardial injury test turnaround time: a college of american pa... 17204519 - Long-term health outcomes associated with detectable troponin i concentrations. 18006459 - Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partia... 3604939 - Nausea and vomiting during acute myocardial infarction and its relation to infarct size... 20609639 - Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of s... |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American heart journal Volume: 161 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-03-11 Completed Date: 2011-05-26 Revised Date: 2012-09-19 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States |
Other Details:
|
Languages: eng Pagination: 611-21 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2011 Mosby, Inc. All rights reserved. |
Affiliation:
|
Tufts Medical Center, Boston, MA 02111, USA. judelson@tuftsmedicalcenter.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angioplasty, Balloon, Coronary Coronary Occlusion / pathology, therapy Female Humans Male Middle Aged Multicenter Studies as Topic Multivariate Analysis Myocardial Infarction / drug therapy, pathology*, therapy Stroke Volume Tomography, Emission-Computed, Single-Photon Ventricular Dysfunction, Left / pathology, physiopathology Ventricular Remodeling* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 HL 075456-04S1/HL/NHLBI NIH HHS; R01 HL075456/HL/NHLBI NIH HHS; R01 HL075456-01/HL/NHLBI NIH HHS; R01 HL075456-02/HL/NHLBI NIH HHS; R01 HL075456-03/HL/NHLBI NIH HHS; R01 HL075456-03S1/HL/NHLBI NIH HHS; R01 HL075456-04/HL/NHLBI NIH HHS; R01 HL075456-04S1/HL/NHLBI NIH HHS; U01HL062509/HL/NHLBI NIH HHS; U01HL062511/HL/NHLBI NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy o...
Next Document: Clinical outcomes after percutaneous revascularization versus medical management in patients with si...